I wanted to share some of the very optimistic news on Omicron that our team of scientists in Open Orphan’s London virology lab are conveying to me. They are now confident that with the onset of Omicron that Covid-19 is following the historic experience of pandemics, that they end with the arrival of a less dangerous but much more contagious variant.
It’s too early to pop the champagne quite yet and far, far, too early to abandon sensible day-to-day precautions, but Omicron may prove to be such a variant. If so then this is the start of the end of the pandemic.
Open Orphan (LON:ORPH) was founded in 2017, with the goal of rapidly building Europe’s leading pharma services company by a management team with extensive industry and financial expertise. The company comprises of two commercial specialist CRO services businesses (Venn Life Sciences and hVIVO) and is also developing a genomics data platform business (Genomic Health Data).
